High expression of Bcl-xL was detected in BRAFV600E-CD207+ cells from LCH lesions and decreased by BRAF or MEK inhibitors, which induce cell death (4, 11, 16). This evidence concerns the gene BCL2L1 and Langerhans cell histiocytosis.